4^th International Conference on Immunology And Immunotherapy November 16-17, 2023 Paris, France

Dr. Tanveer Alam was born in Bijnor, India on 21st Jan. 1974. He received his Ph.D. Degree in the field of Natural Product Chemistry from the School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India in 2000. From Nov. 2000 to Sept. 2001, he was a Post-doctoral Fellow at Jamia Hamdard, New Delhi, India, and worked on the synthesis of water-soluble derivatives of Silymarin. Upon completion of his education, he started his career as an Executive-R&D in a Flavour & Fragrances Company and afterwords he served as Manager & Head-R&D in different National & Multinational Natural Products Industries. Dr. Alam has more than 19 years of R&D experience in the field of Natural Products Chemistry. He has worked as Associate Professor at the Eritrea Institute of Technology, State of Eritrea. He is a Ph.D. supervisor at JJT, University, Rajasthan, India, and Visiting Professor at BioNatural Healing College, California, USA. He is Advisory Board Member in Pharma & Natural Food Colors Industries. He is also a Member of Editorial Boards and Referee for more than thirty National & International Journals. Since March 2015, Dr. Alam is looking for the Production Unit commercialization of Omani Medicinal & Aromatic Plants at the University of Nizwa, Sultanate of Oman.

Pharmaceutical Chemistry (Natural Product Chemistry)

Prof. Dr. C.P Abdolrasoul Aleezaadeh completed his Post Doctorate in (Psychology) at Approach of Applied Clinical Cognitive Neuropsychology in the USA. Prof. Dr. Aleezaadeh Completed his Ph.D. Degrees in Psychology in the USA. He completed his Master's Degree in Clinical Psychology at I. R. of IRAN, Bachelor's Degree in General Psychology at I. R. of IRAN, Bachelor's Degree in Homeopathic Medicine - at I.R of IRAN (Berkeley International University - the USA), and, Advanced Curriculum in Traditional Medicine at W.M.C - I.R of IRAN (Tibbia College Gujranwala - Pakistan). Also, he has five Certificates/Documents in e-Marketing, Marketing, Marketing Management, Sales Management, and Sales Management (A Global Perspective) at Cavendish Caramad Institute - I.R of IRAN (Cavendish College - the UK) and is, Instructor of first aid (initial, complementary and specialized). He is a full Expert International Faculty Professorship Member at the Brooklyn Central University, the USA, Associate Expert International Faculty Professorship Member at the University of Pacific Albion, the USA and, Associate Expert International Faculty Professorship Member at the Green Lake (Green Lake) University, the USA. Now he is working as an Assistant Professor at P.N.U and, U.A.S.

IMMUNOLOGY

MS. SUCHI is an experienced International Pre School Principal/Manager who picked up Laughter exercises from many coaches around the world. She then designed ‘Laughter Therapy' which is being used in many places such as hospitals and Senior Activity Centres. She provides individual and group therapy in educational and home settings. A former Manager / Trainer is now engaged in building social awareness about the Holistic approach to recovery. Be it Depression, Anxiety caused by physical or emotional pain, Death in the family, and the harm the unhappiness brings to people, families, and communities. Her aim is to encourage people to seek help early and get on the path to recovery. Her works has been featured in local press, TV, and Radio, and has been an invited speaker at various community clubs and educational Institutions. She has also been awarded by MINDS and various community clubs in recognition of her social work.

Immunology And Immunotherapy

Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, graduated from Tehran University, School of Medicine with honors. I studied in the neurosurgery ward and graduated with an A score with a thesis on Meningioma Brain Tumors for 6 years. With continuing my practice with special consideration on psychosomatic disorders, I completed many post-graduate courses on health psychology, addiction medicine, and sexual disorders therapy successfully. I passed many post-graduate courses in Neuro, approved by Medical sciences university. As well, I have been passed postgraduate courses in Nutrition, Gastroenterology and hepatology, Obesity treatment, and diabetes approved by the Tehran University of Medical sciences

Immunoinformatics & Systems Immunology

Heisenberg Professor, Group leader and Section Head for Translational Systems Immunology in Hepatogastroenterology, Department of Medicine II, Center for Medicine, Medical Center – University of Freiburg

Systems Immunology in Hepatogastroenterology

Dr. Diab is a clinical investigator whose research is focused on developing new Immunotherapeutic Strategies that will improve clinical outcomes in patients. Building on his extensive background in immunology in general and tumor immunology specifically, Dr. Diab is leading multiple clinical trials involving novel immune modulator agents for Melanoma. In addition, he is leading a program for Interventional Immunotherapy that was established to develop intratumoral therapeutic and tumor vaccination strategies in combination with Systemic therapy

developing new Immunotherapeutic

Dr. Yuhao Jiao, M.D., M.Res, is now a physician and postdoctoral fellow at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. He completed his degree from Tsinghua University and the University of Melbourne. He has a great interest in the field of cancer immunology, mostly focusing on the roles of Innate Lymphoid Cells and their roles in carcinogenesis. He participated in the development of the anti-leukemia drug Venetoclax (ABT-199) and receives royal distributions. His work on optimizing the preconditioning regimen of bone marrow transplantation by manipulating NK cells and studies on depicting the immune landscape of endometrial carcinoma have been widely cited. He is currently working on exploring how NK cells and other subsets of innate lymphoid cells affect the early carcinogenesis of gastrointestinal cancers.

innate lymphoid cells affect the early carcinogenesis of gastrointestinal cancers.

Dr. Nazila Bahmaie was born on the 21st of December 1990 (Ahvaz, Iran). She studied BSc in Cellular and Molecular Biology (Major: Microbiology, IRAN, JULY 2013), and an MSc in Medical Microbiology (at Zanjan University of Medical Sciences, IRAN, SEPTEMBER 2016) which was supervised by Prof. Dr. Abdolreza Esmaeilzadeh. She started her scientific collaborations and academic research in 2013. She has worked as an eminent invited speaker for esteemed scientific events/international congresses and invited authors/reviewers for many scientific journals. Her research interests widely include Cancer, Cancer Immunology, Cancer Immunotherapy, Immuno-oncology, Infectious Diseases, Immunotherapy of Infectious Diseases, Immunopharmacology, Immunopharmaco-oncology, Regenerative Medicine (Clinical Applications of Immune Gene and Immune Cell-based Therapy, Drug Delivery, Monoclonal Antibodies, Vaccines, Stem Cells), Translation Medicine, and Precision Medicine with 17 scientific published articles, more than 40 presentations in national/international congresses/symposiums, and more than 10 submitted/in progress articles. Now, she is a Ph.D. candidate in Cancer Immunology at Ankara Yildirim Beyazit University, Ankara, Turkey which is supervised by Prof. Dr. Ozen Ozensoy Guler.

Immuno-oncology, Infectious Diseases, Immunotherapy of Infectious Diseases, Immunopharmacology, Immunopharmaco-oncology,

I am a passionate scientist with a deeper interest in omics data analysis and pipeline development. I started my career as a Ph.D. student at the CSIR-NBRI Lucknow, India by working on variant analysis in Plants. I was also involved in various other projects as a lead bioinformatician for data analysis for nucleosomal remodeling in plants, Bulk-RNASeq data, and ChIP-Seq data. In June 2017, I joined Dr. Kristel Van steen Bio3 group, GIGA-Medical genomics, University of liege, Belgium to focus my research on marker analysis in PDAC (Pancreatic ductal adenocarcinoma) based on Bulk-RNASeq and Whole exom sequencing data of short and long term PDAC survivors. In October 2020, I joined Prof Dr. Philip Rosenstiel's group at the Institute of Clinical Molecular Biology in Kiel, Germany as a post-doctoral fellow where I got the opportunity to work on spatial transcriptome data to explore the major inflammatory bowel disease Crohn's disease and ulcerative colitis. I am also involved in AI (digital pathology) based project to work on the Whole slides (WS) images of ulcerative colitis and develop the prediction model. My deeper interest in omics data (from Bulk-RNASeq to Spatial transcriptome, AI-based models) and applying different integration approaches have driven me to interact with different people and their cultures. In my professional life, I have developed a keen attitude to learn, propose new projects, and establish techniques and protocols even if they are not used in my laboratory.

Clinical Molecular Biology

Dr. Magali Irla leads the team “Immune Tolerance & T-cell Differentiation” at the Center of Immunology of Marseille Luminy (CIML), Marseille, France(http://www.ciml.univ-mrs.fr/science/lab-magali-irla/immune-tolerance-and-t-cell-differentiation). She has a long-standing interest in the induction of T-cell tolerance that takes place in the thymus. After a Ph.D. in Immunology at Aix-Marseille University, she completed postdoctoral training at the University of Geneva in Switzerland where she studied the differentiation of medullary thymic epithelial cells(mTECs) that control the selection of developing T cells. After being appointed as a junior group leader at the University of Geneva, she joined the CIML where she continues to study the fascinating interplay between mTECs and developing T cells, including Foxp3+ regulatory T cells.

Immune Tolerance & T-cell

Dr. Srinath Balkundhi has completed his Ph.D. in Pharmaceutical Sciences at JNTUA University and Mentor for the postdoctorate scholars. He is working as a professor in Pharmaceutics and Dean, School of Pharmaceutical Sciences Sanjay Ghodawat University Kolhapur Maharashtra, India. He has published more than 25 papers in reputed journals

Pharmaceutical Sciences

Farah is an Assistant lecturer of Microbiology and immunology at the Faculty of Pharmacy, Cairo University. She had a bachelor’s degree in clinical pharmacy from Cairo University in 2016. She achieved her master’s degree in Microbiology from Cairo university. She was awarded the best poster presentation recognition from the international delta university pharmacy conference 2021. She is a member of the American Society of Microbiology (ASM). She is a registered pharmacist at the Egyptian pharmacy syndicate.

Microbiology and immunology

Dr. Indre Plestyte – Butiene, general pediatrician, pediatric pulmonologist, Ph.D. in allergy and immunology since 2013. Assoc. Professor of Klaipeda University (Lithuania), Faculty of health sciences, CEO of a network of pediatric clinics „Mama, I am ill„ in Lithuania. An experienced pediatrician with a strong interest in children's immunology, microbiota, allergology, and lung diseases. Lecturer, researcher, and motivational speaker, author of the book „Why children get sick and how we can help them “. Her work aims to provide a better understanding of the immune system development in childhood and its crosstalk with microbiota, delivering lectures on Environmental health, the impact of the natural environment (pollution of air, water, soil, anthropogenic food pollution, microbes), meteorological and climatic factors, home environmental and psychosocial health of affected populations to prevent diseases and health affections. High interest is indicated in healthy nutrition, and alimentary physical, chemical, and biological safety.

allergy and immunology

Eric Vivier, DVM, Ph.D., is a Professor of Immunology at Aix-Marseille University and at the Public Hospital of Marseille (AP-HM). In addition, he was appointed in 2018, as Scientific Director of Innate Pharma, a biotechnology company dedicated to improving cancer treatment with innovative therapeutic antibodies that exploit the immune system (https://www.innatepharma.com/). He completed his post-doctoral training at Harvard Medical School, then joined Aix-Marseille University as a professor at the Centre d'Immunologie de Marseille-Luminy (CIML) in 1993 before becoming its director from 2008 to 2017. He is also one of the founders of MarseilleImmunopôle, an immunology cluster created in 2014 linking fundamental and therapeutic research, innovation, and industrial development on the Aix-Marseille Metropole (https://marseille-immunopole.org/) Eric Vivier's work focuses on innate immunity and in particular Natural killer and other innate lymphoid cells, at Ciml, at AP-HM, and at Innate-Pharma. Professor Vivier has published over 400 scientific articles and is on the list of the most cited researchers: https://recognition.webofscience.com/awards/highly-cited/2021/ A laureate of the European Research Council (ERC advanced grants), a member of the EMBO, the Académie Nationale de Médecine and the Institut Universitaire de France, Prof. Vivier has received several awards including those from the Ligue Nationale contre le Cancer (and the European Federation of Immunological Societies (EFIS). He is Chevalier de la Légion d’Honneur and Officier de l’Ordre National du Mérite. He is also President of the Paris Saclay Cancer Cluster Association

biotechnology, Immunology